Product Details:
| Minimum Order Quantity | 5 Vial |
| Packaging Type | Pen |
| Treatment | Type 2 Diabetes |
| Strength | 20 mg |
Alluvi Retatrutide 20mg Injection Pen is a, currently experimental, triple-hormone receptor agonist (GIP, GLP-1, and glucagon) designed for significant weight loss,, obesity management, and potential type 2 diabetes treatment.
Additional Information:
- Production Capacity: 100
- Delivery Time: 5 DAYS